$1.44
5.59%
Nasdaq, Nov 02, 12:28 pm EST. Market open.
ISIN
US05280R1005
Symbol
AUTL

Autolus Therapeutics plc Target price 2026 - Analyst rating & recommendation

Autolus Therapeutics plc Classifications & Recommendation

Buy
94%
Hold
6%

Autolus Therapeutics plc Price Target

Target Price $9.18
Price $1.52
Potential
Number of Estimates 11
11 Analysts have issued a price target Autolus Therapeutics plc 2027 . The average Autolus Therapeutics plc target price is $9.18. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 16 analysts: 15 Analysts recommend Autolus Therapeutics plc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Autolus Therapeutics plc stock has an average upside potential 2027 of . Most analysts recommend the Autolus Therapeutics plc stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???

11 Analysts have issued a sales forecast Autolus Therapeutics plc 2026 . The average Autolus Therapeutics plc sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 $75.4m 644.96%
2026
2027
2028
2029
2030
2031
2032
2033

6 Analysts have issued an Autolus Therapeutics plc EBITDA forecast 2026. The average Autolus Therapeutics plc EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-261m 11.87%
2026
2027
2028
2029
2030

EBITDA Margin

2025 -345.84% 84.98%
2026
2027
2028
2029
2030

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

11 Analysts have issued a Autolus Therapeutics plc forecast for earnings per share. The average Autolus Therapeutics plc EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-1.08 25.58%
2026
2027
2028
2029
2030
2031
2032
2033

P/E ratio

Current -1.45 18.63%
2026
2027
2028
2029
2030
2031
2032
2033

Based on analysts' sales estimates for 2026, the Autolus Therapeutics plc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.18 33.97%
2026
2027
2028
2029
2030
2031
2032
2033

P/S ratio

Current 3.58 73.14%
2026
2027
2028
2029
2030
2031
2032
2033

Current Autolus Therapeutics plc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
Analyst Rating Date
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today